Tempest Company Overview, Contact Details & Competitors

Insights

Gathering insights about Tempest…

Similar companies to Tempest

Tempest Tech Stack

Tempest uses 8 technology products and services including WordPress, Microsoft Dynamics, React, and more. Explore Tempest's tech stack below.

WordPress
Content Management System
Microsoft Dynamics
Enterprise Resource Planning
React
Javascript Frameworks
DocuSign
Miscellaneous
Basecamp
Project Management
X-XSS-Protection
Security
Adobe Creative Suite
Visualisation Software
Google Meet
Web Conferencing

Media & News

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full of short-term unregistered warrants $4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full of short-term unregistered warrants
Nov 26, 2025 | www.globenewswire.com
Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
BRISBANE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of 1,172,414 shares of its common stock (or common stock equivalents), at an offering price of $3.625 per share of common stock (or common stock equivalent) in a registered direct offering priced at-the-market under Nasdaq rules.
Nov 25, 2025 | www.globenewswire.com
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027
All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR ⍺ Antagonist, Phase 3-ready) and TPST-1495 (Dual Ep2/4 Antagonist, Phase 2 start expected near term) The anticipated preclosing equity financing and an investment commitment from Factor Bioscience is expected to extend Tempest's runway to mid 2027 and through potentially significant milestones Plan to proceed with execution of globally approved protocol for amezalpat in first-line HCC subject to additional resources or partnerships Matt Angel, Ph.D. to assume role of President and CEO and Stephen Brady to assume role of Chairman of the board of directors upon closing of the acquisition BRISBANE, Calif.
Nov 19, 2025 | www.globenewswire.com
Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update
BRISBANE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today reported financial results for the quarter ended September 30, 2025 and provided a corporate update.
Nov 05, 2025 | www.globenewswire.com
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update
BRISBANE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today reported financial results for the quarter ended June 30, 2025 and provided a corporate update.
Aug 11, 2025 | www.globenewswire.com
Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that the company received approval from the National Medical Products Administration (NMPA) in China to proceed with a pivotal trial to evaluate amezalpat (TPST-1120) in combination with atezolizumab and bevacizumab, the current standard of care, versus the standard of care alone in the first-line treatment of patients with unresectable or metastatic hepatocellular carcinoma (HCC).
Jun 30, 2025 | www.globenewswire.com
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that it has entered into a definitive agreement with a single institutional investor for the purchase and sale in a registered direct offering of 739,000 shares of its common stock (or common stock equivalents), at an offering price of $6.25 per share of common stock (or common stock equivalent).
Jun 11, 2025 | www.globenewswire.com

Tempest's Email Address Formats

Tempest uses at least 1 format(s):

Tempest Email Formats	Example	Percentage
First.Last@tempest.im	John.Doe@tempest.im	64%
First@tempest.im	John@tempest.im	33%
First.Middle@tempest.im	John.Michael@tempest.im	2%
FLast@tempest.im	JDoe@tempest.im	1%

Frequently Asked Questions

Where is Tempest's headquarters located?

Tempest's main headquarters is located at 30 South 15th Street, Ste 800 Philadelphia, Pennsylvania 19102, US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Tempest's phone number?

You can contact Tempest's main corporate office by phone at

+1-800-274-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Tempest's stock symbol?

Tempest is a publicly traded company; the company's stock symbol is TPST.

What is Tempest's official website and social media links?

Tempest's official website is tempest.im and has social profiles on LinkedIn.

What is Tempest's SIC code NAICS code?

Tempest's SIC code is 8742 - Management Consulting Services NAICS code is 541613 - Marketing Consulting Services.

How many employees does Tempest have currently?

As of October 2025, Tempest has approximately 58 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Operating Officer: E. S. A.Chief Technical Officer: J. S.Chief Strategy Officer: R. J.. Explore Tempest's employee directory with LeadIQ.

What industry does Tempest belong to?

Tempest operates in the Advertising Services industry.

What technology does Tempest use?

Tempest's tech stack includes WordPressMicrosoft DynamicsReactDocuSignBasecampX-XSS-ProtectionAdobe Creative SuiteGoogle Meet.

What is Tempest's email format?

Tempest's email format typically follows the pattern of First.Last@tempest.im. Find more Tempest email formats with LeadIQ.

When was Tempest founded?

Tempest was founded in 2010.

Insights

Similar companies to Tempest

GALE

Breeze

Whirlwind

Cyclone

Hurricane

Storm

Informa Investment Solutions

Tornado

Tempest Tech Stack

Media & News

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027

Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update

Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update

Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China

Tempest Announces $4.6 Million Registered Direct Offering of Common Stock

Tempest's Email Address Formats

Frequently Asked Questions

Where is Tempest's headquarters located?

What is Tempest's phone number?

What is Tempest's stock symbol?

What is Tempest's official website and social media links?

What is Tempest's SIC code NAICS code?

How many employees does Tempest have currently?

What industry does Tempest belong to?

What technology does Tempest use?

What is Tempest's email format?

When was Tempest founded?

Tempest

Company Overview

Media & News

Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?